cellulitis_erysipelas%20(pediatric)
CELLULITIS/ERYSIPELAS (PEDIATRIC)
Cellulitis is an acute spreading skin infection that may go deep, involving the subcutaneous tissues.
It typically occurs in areas where the skin integrity has been compromised.
May result from blood-borne spread of infection to the skin and subcutaneous tissues.
It is commonly caused by beta-hemolytic streptococci and Staphylococcus aureus in adults and Haemophilus influenzae type B in patients <3 year of age.

Cellulitis_erysipelas%20(pediatric) Signs and Symptoms

Introduction

  • An acute spreading skin infection that may go deep, involving the subcutaneous tissues
  • Typically occurs in areas where the skin integrity has been compromised
  • May also result from blood-borne spread of infection to the skin & subcutaneous tissues

Definition

Erysipelas

  • A type of cellulitis w/ sharply demarcated margins involving the epidermis & superficial lymphatics
  • Onset of symptoms is acute whereas cellulitis has an indolent course
  • More commonly caused by beta-hemolytic streptococci

Etiology

  • Commonly caused by beta-hemolytic streptococci & Staphylococcus aureus in adults, & Haemophilus influenzae type B in patients <3 years
    • Infection due to streptococci is rapidly spreading because of streptokinase while that of staphylococci is localized
    • Consider Methicillin-resistant S aureus (MRSA) in patients w/ recurrent cellulitis, or refractory to treatment 

Uncomplicated cellulitis

  • Beta-hemolytic streptococcal etiology in 90% of infections but S aureus is difficult to exclude especially if mixed infection occurs

Complicated cellulitis

  • Group A streptococci, Staphylococcus aureus, H influenzae B, Enterobacteriaceae & anaerobes

Signs and Symptoms

  • Rapidly spreading area of acute inflammation of the dermis & subcutaneous tissue
  • Lymphangitis & inflammation of the regional lymph nodes may occur
  • Area is usually tender, erythematous & warm to the touch
  • Patient may have malaise, fever & chills

Risk Factors

  • Obesity
  • Diabetes mellitus & malignancy
  • Immunocompromise
  • Previous cutaneous damage
  • Edema from venous insufficiency or lymphatic obstruction
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
4 days ago
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Pearl Toh, 22 Oct 2020
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Jairia Dela Cruz, 3 days ago
The selective serotonin reuptake inhibitor escitalopram holds promise in the prevention of Alzheimer’s disease, reducing amyloid-β-42 levels in cerebrospinal fluid and brain tissue in older adults with normal cognitive function, according to recent evidence.
Roshini Claire Anthony, 13 Nov 2020

Diabetes is a key risk factor for heart failure (HF), which is the leading cause of hospitalization in patients with or without diabetes. SGLT-2* inhibitors (SGLT-2is) have been shown to reduce the risk of hospitalization for HF (HHF) regardless of the presence or absence of diabetes.